PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Internal Medicine, Rambam Health Care Campus, Haifa, Israel.\', \'Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.\', \'Division of Internal Medicine, Unit of Infectious Diseases, Rambam Healthcare Campus, Haifa, Israel.\', \'Institute of Drug Research, School of Pharmacy-Faculty of Medicine & Institute of Criminology - Faculty of Law. The Hebrew University of Jerusalem, Jerusalem, Israel.\', \'Sheba Medical Center, Geographic Medicine and Tropical Diseases, Ramat Gan, Israel.\', \'Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
  • taab00510.1093/jtm/taab005
?:doi
?:hasPublicationType
?:journal
  • Journal of travel medicine
is ?:pmid of
?:pmid
?:pmid
  • 33480414
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.994
?:rankingScore_hIndex
  • 49
?:title
  • From hydroxychloroquine to ivermectin: what are the anti-viral properties of anti-parasitic drugs to combat SARS-CoV-2?
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all